Difference between revisions of "Team:CSU CHINA/Composite Part"

 
(3 intermediate revisions by the same user not shown)
Line 6: Line 6:
 
<div class="clear"></div>
 
<div class="clear"></div>
  
 +
<center>
 +
<h1>Composite Parts</h1>
 +
</center>
 +
<hr>
  
 +
<div class="block main-text main-text" >
  
−
 
−
 
−
<div class="column full_size">
 
−
<h1>Composite Parts</h1>
 
 
<p>
 
<p>
 
We contributed to the Registry with one supportive part, ready to use in regulating expressions of other proteins . Function of the part was experimentally validated.
 
We contributed to the Registry with one supportive part, ready to use in regulating expressions of other proteins . Function of the part was experimentally validated.
 
</p>
 
</p>
 
<br/>
 
<br/>
−
<img src="https://static.igem.org/mediawiki/2018/e/e1/T--CSU_CHINA--PARTS2.png" />
+
<center>
−
<br/>
+
<img width="400" depth="400" src="https://static.igem.org/mediawiki/2018/e/e1/T--CSU_CHINA--PARTS2.png" />
 +
</center>
 
<p>
 
<p>
 
Promoter CMV can motivate the expression of GAL4-VP16 infusion protein which drives the expression of HSV-thymidine kinase (HSV-TK) to achieve the tumor killing effect as gene therapy.  
 
Promoter CMV can motivate the expression of GAL4-VP16 infusion protein which drives the expression of HSV-thymidine kinase (HSV-TK) to achieve the tumor killing effect as gene therapy.  
 
</p>
 
</p>
−
</div>
+
<center>
−
 
+
 
<img src="https://static.igem.org/mediawiki/2018/a/a2/T--CSU_CHINA--PARTS1.png" />
 
<img src="https://static.igem.org/mediawiki/2018/a/a2/T--CSU_CHINA--PARTS1.png" />
−
<p>
+
</center>
−
[1] Sadowski I, Ma J, Triezenberg S, et al. GAL4-VP16 is an unusually potent transcriptional activator[J]. Nature, 1988, 335(6190): 563.
+
−
</p>
+
 
<br/>
 
<br/>
 
<br/>
 
<br/>
−
 
−
<p>
 
−
A composite part is a functional unit of DNA consisting of two or more basic parts assembled together. <a href="http://parts.igem.org/wiki/index.php/Part:BBa_I13507">BBa_I13507</a> is an example of a composite part, consisting of an RBS, a protein coding region for a red fluorescent protein, and a terminator.
 
−
</p>
 
−
 
−
<p>New composite BioBrick devices can be made by combining existing BioBrick Parts (like Inverters, Amplifiers, Smell Generators, Protein Balloon Generators, Senders, Receivers, Actuators, and so on).</p>
 
−
 
−
<div class="column full_size">
 
−
<div class="highlight decoration_background">
 
−
<h3>Note</h3>
 
−
<p>This page should list all the composite parts your team has made during your project. You must add all characterization information for your parts on the Registry. You should not put characterization information on this page. Remember judges will only look at the first part in the list for the Best Composite Part award, so put your best part first!</p>
 
−
</div>
 
−
</div>
 
−
 
−
 
−
 
−
<div class="column full_size">
 
−
<h3>Best Composite Part Special Prize</h3>
 
−
 
−
<p>To be eligible for this award, this part must adhere to <a href="http://parts.igem.org/DNA_Submission">Registry sample submission guidelines</a> and have been sent to the Registry of Standard Biological Parts. If you have a part you wish to nominate your team for this <a href="https://2018.igem.org/Judging/Awards">special prize</a>, make sure you add your part number to your <a href="https://2018.igem.org/Judging/Judging_Form">judging form</a> and delete the box at the top of this page.
 
−
 
−
<br><br>
 
−
<b>Please note:</b> Judges will only look at the first part number you list, so please only enter ONE (1) part number in the judging form for this prize. </p>
 
−
 
 
</div>
 
</div>
  
 
</html>
 
</html>

Latest revision as of 02:39, 18 October 2018


Composite Parts

We contributed to the Registry with one supportive part, ready to use in regulating expressions of other proteins . Function of the part was experimentally validated.


Promoter CMV can motivate the expression of GAL4-VP16 infusion protein which drives the expression of HSV-thymidine kinase (HSV-TK) to achieve the tumor killing effect as gene therapy.